1Niccoli G, Sgueglia GA, Latib A, et al. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: A CACTUS study subanalysis. Catheter Cardiovasc Interv, 2014, 83: E37-E44.
2Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coil Cardiol, 2007, 50: 2173-2195.
3Oh JK, Shub C, Ilstrup DM, et al. Creatine kinase release after successful percutaneous translumlnal coronary angioplasty. Am Heart J, 1985, 109: 1225-1231.
4Ellis SG, Chew D, Chan A, et al. Death following creatine kinase- MB elevation after coronary intervention identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation, 2002, 106: 120-';-1210.
5Prasad A, Gersh B J, Bertrand ME, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) lrial. J Am Coil Cardiol, 2009, 54: 477-486.
6Lo N, Michael TT, Moin D, et al. Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study. JACC Cardiovasc lnterv, 2014, 7: 47-54.
7Hovens MM, Snoep JD, Eikenboom JC, et al. Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J, 2007, 153: 175-181.
8Silber S, Albertsson P, Avil 6 s FF, et al. Guidelines for percutaneous coronary interventions the task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J, 2005, 26: 804-847.
9Moore RK, Lowe R, Grayson AD, et al. A study comparing the incidence and predictors of creatine kinase MB and troponin T release after coronary angioplasty. Does clopidogrel preloading reduce myocardial necrosis following elective percutaneous coronary intervention? Int J Cardiol, 2007, 116: 93-97.
10Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA, 2002, 288:2411-2420.
二级参考文献12
1Bonello L, Sbragia P, Amabile N, et al. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury followingpercutaneous coronary intervention. Heart, 2007, 93: 703-707.
2Ito N, Nanto S, Doi Y, et al. High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intraeoronary administration of nicorandil. (]ire J, 2010, 74: 909-915.
3Isono T, Kamihata H, Sutani Y, et al. Nicorandil suppressed myocardial injury after percutaneous coronary intervention. Int J Cardiol, 2008, 123: 123-128.
4Babu GG, Walker JM, Yellnn DM, et al. Peri-procedural myocardial injury during percutaneous coronary intervention: animportant target for cardioprotection. Eur Heart J, 2011.32: 23-31.
5Kawai Y, Hisamatsu K, Matsllbara H, et al. Intravenous administration of nicorandil immediately before percutaneous coronaryintervention can prevent slow coronary flow phenomenon. Eur Heart J, 2009, 30: 765-772.
6Ono H, Osanai T, lshizaka H, et al. Nicorandil improves cardiac function and clinical outcome in patients with acute myoeardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J, 2004, 148: El5.
7Krolikowski JG, Bienengraeber M, Weihrauch D, et al. Inhibition of mitochondrial permeability transition enhances isoflurane-induced eardioprotectiun during early reperfusion: the role of mitoehondrial KATPcbannels. Anesth Analg, 2005, 101: 1590-1596.
8Khode V, Sindhur J, Kanbur D, et al. Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study. J Cardiovasc Dis Res, 2012, 3: 272-275.
9Murat SN, Duran M, Kalay N, et al. Relation Between Mean Platelet Volume and Severity of Atherosclerosis in Patients With Ac, ute Coronary Syndromes. Angiology, 2012, 64:131-136.
